Sarah  Condella net worth and biography

Sarah Condella Biography and Net Worth

Sarah Condella has served as our Executive Vice President, Human Resources since January 2021, and previously served in increasing roles of responsibility, including as Senior Vice President, Human Resources; Vice President; Senior Director; and Director, since joining Exact Sciences in 2012. Prior to joining Exact Sciences, Ms. Condella served as a Human Resources Manager at GE Healthcare and as a Manager and Project Director at the University of Wisconsin Survey Center. She holds a bachelor’s degree and a Master of Business Administration from the University of Wisconsin-Madison. Ms. Condella is a member of the Society for Human Resource Management (SHRM) and currently serves on the boards of the Madison Children's Museum and Gilda’s Club.

What is Sarah Condella's net worth?

The estimated net worth of Sarah Condella is at least $4.26 million as of April 1st, 2024. Ms. Condella owns 71,787 shares of Exact Sciences stock worth more than $4,264,148 as of December 21st. This net worth approximation does not reflect any other assets that Ms. Condella may own. Additionally, Ms. Condella receives an annual salary of $742,760.00 as SVP at Exact Sciences. Learn More about Sarah Condella's net worth.

How old is Sarah Condella?

Ms. Condella is currently 43 years old. There are 6 older executives and no younger executives at Exact Sciences. The oldest executive at Exact Sciences is Mr. Kevin T. Conroy, Chairman of The Board & CEO, who is 58 years old. Learn More on Sarah Condella's age.

What is Sarah Condella's salary?

As the SVP of Exact Sciences Co., Ms. Condella earns $742,760.00 per year. There are 3 executives that earn more than Ms. Condella. The highest earning executive at Exact Sciences is Mr. Kevin T. Conroy, Chairman of The Board & CEO, who commands a salary of $3,140,000.00 per year. Learn More on Sarah Condella's salary.

How do I contact Sarah Condella?

The corporate mailing address for Ms. Condella and other Exact Sciences executives is 5505 ENDEAVOR LANE, MADISON WI, 53719. Exact Sciences can also be reached via phone at (608) 284-5700 and via email at [email protected]. Learn More on Sarah Condella's contact information.

Has Sarah Condella been buying or selling shares of Exact Sciences?

Sarah Condella has not been actively trading shares of Exact Sciences over the course of the past ninety days. Most recently, Sarah Condella sold 2,000 shares of the business's stock in a transaction on Monday, April 1st. The shares were sold at an average price of $70.00, for a transaction totalling $140,000.00. Following the completion of the sale, the executive vice president now directly owns 71,787 shares of the company's stock, valued at $5,025,090. Learn More on Sarah Condella's trading history.

Who are Exact Sciences' active insiders?

Exact Sciences' insider roster includes Brian Baranick (Insider), Sarah Condella (SVP), Kevin Conroy (CEO), D. Coward (Insider), Everett Cunningham (Insider), James Doyle (Director), Jeffrey Elliott (CFO), James Herriott (General Counsel), Torsten Hoof (Insider), Daniel Levangie (Director), Graham Lidgard (Insider), Jacob Orville (Insider), and Katherine Zanotti (Director). Learn More on Exact Sciences' active insiders.

Are insiders buying or selling shares of Exact Sciences?

In the last twelve months, Exact Sciences insiders bought shares 1 times. They purchased a total of 19,500 shares worth more than $1,001,325.00. In the last twelve months, insiders at the medical research company sold shares 35 times. They sold a total of 75,348 shares worth more than $4,597,043.93. The most recent insider tranaction occured on November, 13th when CEO Kevin T Conroy bought 19,500 shares worth more than $1,001,325.00. Insiders at Exact Sciences own 1.4% of the company. Learn More about insider trades at Exact Sciences.

Information on this page was last updated on 11/13/2024.

Sarah Condella Insider Trading History at Exact Sciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2024Sell2,000$70.00$140,000.0071,787View SEC Filing Icon  
3/28/2024Sell2,000$70.00$140,000.0073,787View SEC Filing Icon  
3/1/2024Sell1,724$59.32$102,267.6875,787View SEC Filing Icon  
2/27/2024Sell1,880$56.89$106,953.2073,732View SEC Filing Icon  
2/23/2024Sell1,021$59.72$60,974.1271,658View SEC Filing Icon  
2/21/2024Sell1,079$61.50$66,358.5071,658View SEC Filing Icon  
2/15/2024Sell965$61.43$59,279.9570,489View SEC Filing Icon  
1/2/2024Sell2,000$73.50$147,000.0069,423View SEC Filing Icon  
12/14/2023Sell2,000$70.00$140,000.0071,423View SEC Filing Icon  
5/10/2023Sell6,087$80.00$486,960.0080,314View SEC Filing Icon  
5/1/2023Sell1,000$63.78$63,780.0086,401View SEC Filing Icon  
4/3/2023Sell1,000$67.19$67,190.0086,692View SEC Filing Icon  
2/28/2023Sell2,924$61.12$178,714.8888,692View SEC Filing Icon  
2/15/2023Sell954$65.59$62,572.8685,166View SEC Filing Icon  
1/9/2023Sell1,000$60.00$60,000.0085,090View SEC Filing Icon  
3/1/2022Sell2,816$76.69$215,959.04View SEC Filing Icon  
2/23/2022Sell1,124$69.05$77,612.20View SEC Filing Icon  
2/15/2022Sell938$79.55$74,617.90View SEC Filing Icon  
6/10/2021Sell5,450$120.00$654,000.0074,380View SEC Filing Icon  
3/2/2021Sell1,679$138.42$232,407.1875,731View SEC Filing Icon  
2/24/2021Sell2,057$136.30$280,369.1073,004View SEC Filing Icon  
See Full Table

Sarah Condella Buying and Selling Activity at Exact Sciences

This chart shows Sarah Condella's buying and selling at Exact Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Exact Sciences Company Overview

Exact Sciences logo
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Read More

Today's Range

Now: $59.40
Low: $55.98
High: $59.70

50 Day Range

MA: $61.91
Low: $49.33
High: $71.93

2 Week Range

Now: $59.40
Low: $40.62
High: $79.62

Volume

3,273,828 shs

Average Volume

2,615,913 shs

Market Capitalization

$10.99 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.24